NK
Insider
Neil Kumar
Chief Executive OfficerNeil Kumar (Chief Executive Officer) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $6.0M of BBIO (80,000 sh across 8 lots, as filed), executed Apr 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
14
0 buys · 14 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$60.7M
shares × price, as filed
Last traded
Sep 17
Filed yesterday
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $107.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
15 filings
Sector per market data · by filing · past 12 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$5.7M80,000 sh across 12 lots
Exec Feb 10
Filed Feb 12 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $6.0M
78,925 sh across 11 lots
Exec Jan 8
Filed Jan 12 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $2.2M
30,011 sh across 2 lots
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $5.9M
80,000 sh across 10 lots
Exec Dec 4 2025
Filed Dec 8 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $1.7M
26,156 sh across 3 lots
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $4.9M
79,380 sh across 8 lots
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $4.4M
80,000 sh across 6 lots
Exec Oct 8 2025
Filed Oct 10 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $4.1M
78,300 sh across 8 lots
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET More filings →